UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

Targeted oncology, 2017-02, Vol.12 (1), p.19-35

2017

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.913-921

2021

Volltextzugriff (PDF)

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

Clinical & translational oncology, 2021-04, Vol.23 (4), p.764-772

2021

Volltextzugriff (PDF)

Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.1001-1001

2021

Volltextzugriff (PDF)

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

British journal of cancer, 2010-06, Vol.102 (12), p.1687-1691

2010

Volltextzugriff (PDF)

MON-PP069: Efficacy of a Diarrhea Protocol with Oligomer Enteral Nutrition in Oncological Patients Under Chemotherapy and/or Radiotherapy

Clinical nutrition (Edinburgh, Scotland), 2015-09, Vol.34, p.S153-S153

2015

Volltextzugriff (PDF)

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

Annals of oncology, 2016-04, Vol.27 (4), p.706-711

2016

Volltextzugriff (PDF)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Clinical & translational oncology, 2021-08, Vol.23 (8), p.1666-1677

2021

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

Clinical & translational oncology, 2018-01, Vol.20 (1), p.75-83

2018

Volltextzugriff (PDF)

Dendritic cell uptake of iron-based magnetic nanoparticles

Cell biology international, 2008-08, Vol.32 (8), p.1001-1005

2008

Volltextzugriff (PDF)

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer

Nature genetics, 2008-06, Vol.40 (6), p.703-706

2008

Volltextzugriff (PDF)

POSB237 Measures to Evaluate Quality of Care in Head and Neck Cancer: Interim Results of a Delphi Study

Value in health, 2022-01, Vol.25 (1), p.S160-S160

2022

Volltextzugriff (PDF)

8520 Preliminary results of a pilot study with a modified induction docetaxel/cisplatin/5-FU (TPF) followed by concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC)

European journal of cancer supplements, 2009, Vol.7 (2), p.476-477

2009

Volltextzugriff (PDF)

Changing trends in HIV and cancer

Annals of oncology, 2016-10, Vol.27, p.vi481-vi481

2016

Volltextzugriff (PDF)

Phase II study of capecitabine as palliative treatment for patients (p) with squamous head and neck cancer (HNC) with locoregional and/or metastatic relapse after previous platinum-based treatment (PBT): Final results of Spanish Head and Neck Cancer Group (TTCC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.6047-6047

2009

Volltextzugriff (PDF)

A pilot study of modified neoadjuvant docetaxel/cisplatin/5-FU (TPF) to concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC): Preliminary results

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.6039-6039

2009

Volltextzugriff (PDF)

Fever in cancer patients as a cause of attendance in emergency room

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20706-e20706

2009

Volltextzugriff (PDF)

Oncologic patients in the emergency room

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20748-e20748

2009

Volltextzugriff (PDF)

Evaluation of neurological symptoms in oncologic patients at the emergency department

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20728-e20728

2009

Volltextzugriff (PDF)

Dyspnea in oncologic patients as an important cause of attendance in emergency room

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20705-e20705

2009

Volltextzugriff (PDF)

Anemia evaluation in oncologic patients in the emergency room

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20714-e20714

2009

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

MON-PP069: Efficacy of a Diarrhea Protocol with Oligomer Enteral Nutrition in Oncological Patients Under Chemotherapy and/or Radiotherapy

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

Dendritic cell uptake of iron-based magnetic nanoparticles

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer

POSB237 Measures to Evaluate Quality of Care in Head and Neck Cancer: Interim Results of a Delphi Study

SPAZO2 (SOGUG): Comparative effectiveness of everolimus (Ev) vs axitinib (Ax) as second-line after first-line pazopanib (1stPz) in metastatic renal carcinoma (mRC)

8520 Preliminary results of a pilot study with a modified induction docetaxel/cisplatin/5-FU (TPF) followed by concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC)

1128PFinal results of a phase II study of induction chemotherapy (CT) with paclitaxel (PTX) and panitumumab (P) followed by radiotherapy (RT) and P in patients (pts) with locally advanced head and neck cancer (LAHNC) no candidates to platinum: Study PANTERA

1128P - Final results of a phase II study of induction chemotherapy (CT) with paclitaxel (PTX) and panitumumab (P) followed by radiotherapy (RT) and P in patients (pts) with locally advanced head and neck cancer (LAHNC) no candidates to platinum: Study PANTERA

Final results of a phase II study of induction chemotherapy (CT) with paclitaxel (PTX) and panitumumab (P) followed by radiotherapy (RT) and P in patients (pts) with locally advanced head and neck cancer (LAHNC) no candidates to platinum: Study PANTERA

Changing trends in HIV and cancer

Phase II study of capecitabine as palliative treatment for patients (p) with squamous head and neck cancer (HNC) with locoregional and/or metastatic relapse after previous platinum-based treatment (PBT): Final results of Spanish Head and Neck Cancer Group (TTCC)

A pilot study of modified neoadjuvant docetaxel/cisplatin/5-FU (TPF) to concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC): Preliminary results

Fever in cancer patients as a cause of attendance in emergency room

Oncologic patients in the emergency room

Evaluation of neurological symptoms in oncologic patients at the emergency department

Dyspnea in oncologic patients as an important cause of attendance in emergency room

Anemia evaluation in oncologic patients in the emergency room

Suchergebnisse filtern